24 November 2021 |
| 08:50-09:00 | | Welcome and Introduction Chair(s): Anitha Kumaran (Southampton, UK)
|
| 09:00-10:15 | | CME Session 1 Chair(s): Anitha Kumaran (Southampton, UK) and James Law (Nottingham, UK)
|
| 09:00 | | Epidemiology of adrenal crisis in children |
| 09:30 | | Kidney speaks - Interpreting kidney function tests in disorders of salt and water balance |
| 10:00 | | Q&A |
| 10:15-10:45 | | CME Case Presentations 1 Chair(s): Anitha Kumaran (Southampton, UK) and James Law (Nottingham, UK)
|
| 10:15 | OC1.1 | Severe hypercalcaemia in Williams-Beuren syndrome |
| 10:25 | OC1.2 | Two cases of functioning adrenocortical tumours secondary to TP53 variants |
| 10:35 | | Q&A |
| 10:45-11:00 | | Break
|
| 11:00-12:15 | | CME Session 2 Chair(s): Anitha Kumaran (Southampton, UK) and Charlotte Elder (Sheffield, UK)
|
| 11:00 | | Update in the recognition and management of adolescent PCOS |
| 11:30 | | Approach to a viralising girl in puberty |
| 12:00 | | Q&A |
| 12:15-12:45 | | CME Case Presentations 2 Chair(s): Anitha Kumaran (Southampton, UK) and Charlotte Elder (Sheffield, UK)
|
| 12:15 | OC2.1 | Pitfalls and challenges in the diagnosis and management of Cushing’s disease in children: An interesting case |
| 12:25 | OC2.2 | Two cases of McCune-Albright Syndrome with multisystem involvement |
| 12:35 | | Q&A |
| 12:45-12:55 | | CSAC Trainee Representative
|
| 12:55-13:55 | | Lunch
|
| 13:55-15:10 | | CME Session 3 Chair(s): Anitha Kumaran (Southampton, UK) and Senthil Senniappan (Liverpool, UK)
|
| 13:55 | | Controversies in management of neonatal hypoglycaemia |
| 14:25 | | Hypothalamic obesity post cancer treatment - optimising outcomes |
| 14:55 | | Q&A |
| 15:10-15:15 | | CME Case Presentations 3 Chair(s): Anitha Kumaran (Southampton, UK) and Senthil Senniappan (Liverpool, UK)
|
| 15:10 | OC3.1 | Rapid-Onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome (ROHHAD-NET): Case series & learning points |
| 15:15 | OC3.2 | Variable responses to sulfonylurea treatment in siblings from the same family with monogenic diabetes due to HNF1A mutation |
| 15:20 | | Q&A |
| 15:25-15:40 | | Break
|
| 15:40-16:40 | | CME Session 4 Chair(s): Anitha Kumaran (Southampton, UK) and Dr Sophia Sakka (London, UK)
|
| 15:40 | | Updating Diabetes care with advances in diabetes technology and digital health |
| 16:05 | | Hypoglycemia unawareness in type 1 diabetes – lessons learnt |
| 16:30 | | Q&A |
| 16:40-16:55 | | CME Officer's Update
|
25 November 2021 |
| 07:45-08:45 | | Industry Sponsored Satellite Symposium
|
| 08:45-09:00 | | Break
|
| 09:00-09:10 | | Welcome from BSPED President and Chair Chair(s): Tabitha Randell (Nottingham, UK) & Senthil Senniappan (Liverpool, UK)
|
| 09:10-10:40 | | Endocrine Oral Comms 1 Chair(s): Hoong-Wei Gan (London, UK) and Justin Davies (Southampton, UK)
|
| 09:10 | OC4.1 | Dominant Mutations in CCDC141 are found by Whole Exome Sequencing to be a Common Cause of Self-Limited Delayed Puberty |
| 09:18 | OC4.2 | Pseudohypoparathyroidism type 1A and 1B: presentation, phenotypes and phenotype-genotype associations |
| 09:26 | OC4.3 | Growth hormone receptor 6Ω pseudoexon activation: a novel cause of severe growth hormone insensitivity |
| 09:32 | OC4.4 | Does Inflammation Underpin Polycystic Ovary Syndrome (PCOS)? A Proteomic Approach to Novel Non-Invasive Biomarker and Pathway Discovery in Adolescent PCOS |
| 09:40 | | Q&A |
| 09:48 | OC4.5 | The biochemical evaluation of Metabolic Bone Disease of Prematurity (MBDP) in a high-risk population |
| 09:56 | OC4.6 | The management of adrenal cell carcinoma in the United Kingdom at a single centre: a 25 year experience |
| 10:04 | OC4.7 | The use of urinary steroid profiles in monitoring therapy in children with 21-hydroxylase deficiency – results from the CAH-UK cohort study |
| 10:12 | OC4.8 | Destination outcome of 1151 gender variant young people presenting to paediatric endocrinology clinics in England and Wales since 2008 |
| 10:20 | OC4.9 | The use of Liraglutide in the treatment of childhood obesity |
| 10:28 | | Q&A |
| 09:10-10:40 | | Diabetes Symposium 1 Chair(s): Tabitha Randell (Nottingham, UK) and Amanda Peacock (Leeds, UK)
|
| 09:10 | | Low carbohydrate diets in type 1 diabetes |
| 09:30 | | Eating disorder risk in weight management |
| 09:50 | | Low carbohydrate diets in type 2 diabetes |
| 10:10 | | Q&A |
| 10:40-10:55 | | Break
|
| 10:55-11:55 | | Endocrine Symposium 1 Chair(s): Guftar Shaikh (Glasgow, UK) and Senthil Senniappan (Liverpool, UK)
|
| 10:55 | | Fertility preservation in boys |
| 11:15 | | Turner syndrome adolescence and beyond |
| 11:35 | | Q&A |
| 10:55-11:55 | | Diabetes Symposium 2 Chair(s): Noina Abid (Belfast, Northern Ireland) and Neil Wright (Sheffield, UK)
|
| 10:55 | | Controversies in the management of DKA |
| 11:15 | | Type 1 diabetes: moving into adulthood |
| 11:35 | | Q&A |
| 11:55-12:25 | | Endocrine Oral Comms 2 Chair(s): Renuka Dias (Birmingham, UK) and Pooja Sachdev (Nottingham, UK)
|
| 11:55 | OC5.1 | Evaluating UK Referral Criteria for Children with Short Stature in a Tertiary Paediatric Endocrinology Centre |
| 12:00 | OC5.2 | Evaluation of the discrepancy between free thyroxine (FT4) reference ranges and the impact on clinical investigation of central hypothyroidism |
| 12:05 | OC5.3 | An Investigation Of Androgen-responsive Non-coding RNAs In Boys With Atypical Genitalia Without Genetic Variants in the Androgen Receptor (AR) |
| 12:10 | OC5.4 | Virtual exercise sessions: An innovative way of promoting physical activity in children and young people with obesity |
| 12:15 | OC5.5 | B-cell class switching in trans- and cis-gendered healthy young people is differentially influenced by sex hormones |
| 12:20 | | Q&A |
| 11:55-12:25 | | Diabetes Oral Comms 1 Chair(s): Melanie Kershaw (Birmingham, UK) and May Ng (Liverpool, UK)
|
| 11:55 | OC7.1 | Utility of glycated haemoglobin in assessing abnormal glucose homeostasis in children and adolescents with obesity undergoing oral glucose tolerance test |
| 12:00 | OC7.2 | Multi-Centre Service Evaluation of Presentation of Newly Diagnosed Type 1 Diabetes in Children in the U.K. During the COVID-19 Pandemic |
| 12:05 | OC7.3 | Hybrid closed-loop in children and young people with type 1 diabetes improves glycaemic management and quality of life measures |
| 12:10 | OC7.4 | Patient experiences of the changes made to the Cardiff and Vale University Health Board Paediatric Diabetes service due to COVID-19 |
| 12:15 | OC7.5 | Screening for Eating Disorders in Young People with Type 1 Diabetes |
| 12:20 | | Q&A |
| 12:25-12:40 | | Break
|
| 12:40-13:10 | | Industry Sponsored Expert Insights Session
|
| 12:40-13:10 | | Industry Sponsored Expert Insights Session
|
| 13:10-14:10 | | Lunch
|
| 14:10-14:40 | | Awards Session - James M Tanner Award Chair(s): Tabitha Randell (Nottingham, UK) and Senthil Senniappan (Liverpool, UK)
|
| 14:40-14:55 | | Break
|
| 14:55-15:55 | | Endocrine Symposium 2 Chair(s): Gary Butler (London, UK) and Bindu Avatapalle (Cardiff, UK)
|
| 14:55 | | GnRH analogues for gender dysphoria |
| 15:15 | | Using AMH and inhibin B assays in children and young people |
| 15:35 | | Q&A |
| 14:55-15:55 | | Diabetes Symposium 3 Chair(s): Ritika Kapoor (London, UK) and Chizo Agwu (Birmingham, UK)
|
| 14:55 | | Early detection of neonatal diabetes |
| 15:15 | | 100 years of insulin - is it time for a UK Type 1 diabetes screening strategy? |
| 15:35 | | Q&A |
| 15:55-16:10 | | Break
|
| 16:05-16:45 | | Personal Practice Session Chair(s): Mehul Dattani (London, UK) and Nikki Davis (Southampton, UK)
|
| 16:05 | | Medical management of T2DM in adolescents |
| 16:20 | | Management of thyroid nodules in children |
| 16:35 | | Q&A |
| 16:10-16:40 | | Endocrine Oral Comms 3 Chair(s): Dinesh Giri (Bristol, UK) and Nils Krone (Sheffield, UK)
|
| 16:10 | OC6.1 | Novel dominant negative GH receptor variants provide important insights into GH receptor physiology |
| 16:15 | OC6.2 | Body composition in adults with genetically-confirmed Silver-Russell syndrome |
| 16:20 | OC6.3 | Topiramate as a treatment option in managing obesity complicated by idiopathic intracranial hypertension and chronic migraine in children and adolescents |
| 16:25 | OC6.4 | Final height SDS of paediatric patients with ESRF that underwent renal transplantation |
| 16:30 | OC6.5 | Highlighting POLE1 mutations as a cause of adrenal insufficiency |
| 16:35 | | Q&A |
| 16:40-16:55 | | Break
|
| 16:55-18:15 | | AGM
|
26 November 2021 |
| 09:00-09:30 | | Endocrine Nurses Business Meeting
|
| 09:30-11:00 | | Diabetes Symposium 4 Chair(s): Evelien Gevers (London, UK) and Fiona Campbell (Leeds, UK)
|
| 09:30 | | Optimising time in range using continuous glucose monitoring |
| 09:50 | | Real world use of the closed loop insulin delivery system |
| 10:10 | | Personalising insulin therapy using smart pumps, pens and automated insulin delivery systems |
| 10:30 | | Q&A |
| 09:30-11:00 | | Endocrine Symposium 3 Chair(s): Lee Martin (London, UK) and Isabelle Sharratt (London, UK)
|
| 09:30 | | Non-medical prescribing: how can you make a difference to your service as a non-medical prescriber? |
| 09:50 | | Advanced nurse practice: what is advanced nurse practice? |
| 10:10 | | Running a Paediatric Endocrine Nurse clinic: benefits and tips for success |
| 10:30 | | Q&A |
| 11:00-11:15 | | Break
|
| 11:15-12:45 | | Diabetes Oral Comms 2 Chair(s): Chris Moudiotis (Exeter, UK) and Rathi Prasad (London, UK)
|
| 11:15 | OC8.1 | Cystic fibrosis related diabetes (CFRD): could Cystic Fibrosis Transport Receptor (CFTR) modulators be the answer? |
| 11:23 | OC8.2 | The cost of diabetes school training was halved whilst training 25% more staff during COVID-19 using multi-media interactive care plans |
| 11:31 | OC8.3 | Nottingham’s Robin Hood approach to socioeconomic and ethnic disparities in paediatric diabetes |
| 11:39 | OC8.4 | Developing a clinical decision aid for paediatric diabetic ketoacidosis: the DKA Calculator |
| 11:47 | | Q&A |
| 11:55 | OC8.5 | Permanent neonatal diabetes due to KCNJ11 mutation: early successful transition to Glibenclamide and stable glucose profile with multiple daily dosing |
| 12:03 | OC8.6 | Evaluation of the diabetes education app |
| 12:11 | OC8.7 | HENRY: High HbA1c service Evaluation 2016-2019: New “tipping point” in contactRequired for CYPwD |
| 12:19 | OC8.8 | Barriers to uploading diabetes technology at home |
| 12:27 | OC8.9 | Virtual Sessions 'Cook and Count' for Young People with Type 1 Diabetes, Using PDSA Cycles, Meeting Young Peoples Wishes |
| 12:35 | | Q&A |
| 11:15-12:15 | | Endocrine Oral Comms 4 Chair(s): Susan Sparrow (Cambridge, UK) and Karis Reyes (Cambridge, UK)
|
| 11:15 | OC9.4 | Changes in trends in Short Synacthen Test use over a decade - a single centre experience |
| 11:22 | OC9.1 | Variability in the diagnosis of growth hormone deficiency using dynamic tests. Time for robust pre-test criteria? |
| 11:29 | OC9.2 | Sex Steroid Priming for Growth Hormone Stimulation Testing – A Systematic Review |
| 11:36 | OC9.3 | Investigating paediatric weight management apps |
| 11:43 | OC9.5 | Variability of advice and education for steroid sick day dosing in Duchenne Muscular Dystrophy: Results of a UK patient survey |
| 11:50 | OC9.6 | 'Think Adrenal': An innovative trust-wide safety and education programme designed for the care of patients with adrenal insufficiency |
| 11:57 | | Q&A |
| 12:15-12:45 | | Presentations from Previous Award Winners Chair(s): Christina Wei (London, UK) and Jo Blair (Liverpool, UK)
|
| 12:15 | | BSPED Research & Innovation Award Winner 2017 |
| 12:23 | | BSPED Research & Innovation Award Winner 2018 |
| 12:31 | | BSPED Research & Innovation Award Winner 2018 |
| 12:39 | | Q&A |
| 12:45-13:15 | | Lunch
|
| 13:15-13:45 | | Industry Sponsored Expert Insights Session
|
| 13:45-14:00 | | Break
|
| 14:00-15:30 | | Diabetes Symposium 5 Chair(s): Mars Skae (Manchester, UK) and Nicola Bridges (London, UK)
|
| 14:00 | | Effect of CFTR modulator therapy on cystic fibrosis-related diabetes |
| 14:20 | | Evaluation and Management of Genetic forms of Obesity |
| 14:40 | | Psychoeducation and changing behaviour: Knowing how doesn’t always mean action |
| 15:00 | | Q&A |
| 14:00-15:30 | | Endocrine Symposium 4 Chair(s): Raja Padidela (Manchester, UK) and Renuka Ramakrishnan (Liverpool, UK)
|
| 14:00 | | Interpretation of abnormal thyroid function tests in children and adolescents |
| 14:20 | | Metabolic bone disease of prematurity: recognition, prevention and treatment |
| 14:40 | | Newer treatment options for childhood obesity management |
| 15:00 | | Q&A |
| 15:30-15:45 | | Break
|
| 15:45-16:00 | | BSPED 2021 Awards Session Chair(s): Sabah Alvi (Leeds, UK) and Helen Storr (London, UK)
|
| 16:00-16:15 | | Close of Meeting Chair(s): Senthil Senniappan (Liverpool, UK)
|